Poole EM - Search Results

1

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS.

Zivadinov R, Dwyer MG, Carl E, Poole EM, Cavalier S, Briassouli P, Bergsland N. Zivadinov R, et al. Among authors: poole em. Ther Adv Neurol Disord. 2020 Nov 11;13:1756286420970754. doi: 10.1177/1756286420970754. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 33240397 Free PMC article.

2

Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study.

Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Poole EM, Robinson M, Gold R. Coyle PK, et al. Among authors: poole em. Mult Scler Relat Disord. 2019 Jun;31:157-164. doi: 10.1016/j.msard.2019.03.022. Epub 2019 Mar 30. Mult Scler Relat Disord. 2019. PMID: 31005729 Free article. Clinical Trial.

3

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide.

Sprenger T, Kappos L, Radue EW, Gaetano L, Mueller-Lenke N, Wuerfel J, Poole EM, Cavalier S. Sprenger T, et al. Among authors: poole em. Mult Scler. 2020 Sep;26(10):1207-1216. doi: 10.1177/1352458519855722. Epub 2019 Jun 14. Mult Scler. 2020. PMID: 31198103 Free PMC article.

4

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis.

Comi G, Freedman MS, Meca-Lallana JE, Vermersch P, Kim BJ, Parajeles A, Edwards KR, Gold R, Korideck H, Chavin J, Poole EM, Coyle PK. Comi G, et al. Among authors: poole em. BMC Neurol. 2020 Oct 6;20(1):364. doi: 10.1186/s12883-020-01937-4. BMC Neurol. 2020. PMID: 33023488 Free PMC article. Clinical Trial.

5

Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials.

Comi G, Miller AE, Benamor M, Truffinet P, Poole EM, Freedman MS. Comi G, et al. Among authors: poole em. Mult Scler. 2020 Aug;26(9):1083-1092. doi: 10.1177/1352458519851981. Epub 2019 Jun 7. Mult Scler. 2020. PMID: 31172849 Free PMC article.

6

Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studies.

Sprenger T, Kappos L, Sormani MP, Miller AE, Poole EM, Cavalier S, Wuerfel J. Sprenger T, et al. Among authors: poole em. Mult Scler. 2022 Oct;28(11):1719-1728. doi: 10.1177/13524585221089534. Epub 2022 Apr 29. Mult Scler. 2022. PMID: 35485424 Free PMC article.

7

Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies.

Oh J, Vukusic S, Tiel-Wilck K, Inshasi JS, Rog D, Baker DP, Pyatkevich Y, Poole EM, Vermersch P. Oh J, et al. Among authors: poole em. J Cent Nerv Syst Dis. 2021 Jul 29;13:11795735211028781. doi: 10.1177/11795735211028781. eCollection 2021. J Cent Nerv Syst Dis. 2021. PMID: 34377047 Free PMC article.

8

Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience.

Vukusic S, Coyle PK, Jurgensen S, Truffinet P, Benamor M, Afsar S, Purvis A, Poole EM, Chambers C. Vukusic S, et al. Among authors: poole em. Mult Scler. 2020 Jun;26(7):829-836. doi: 10.1177/1352458519843055. Epub 2019 Apr 10. Mult Scler. 2020. PMID: 30968734

9

Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide.

Henson LJ, Afsar S, Davenport L, Purvis A, Poole EM, Truffinet P. Henson LJ, et al. Among authors: poole em. Reprod Toxicol. 2020 Aug;95:45-50. doi: 10.1016/j.reprotox.2020.04.073. Epub 2020 May 11. Reprod Toxicol. 2020. PMID: 32407881 Free article.

10

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years.

Horáková D, Boster A, Bertolotto A, Freedman MS, Firmino I, Cavalier SJ, Jacobs AK, Thangavelu K, Daizadeh N, Poole EM, Baker DP, Margolin DH, Ziemssen T; CARE-MS I, CARE-MS II, and CAMMS03409 Investigators. Horáková D, et al. Among authors: poole em. Mult Scler J Exp Transl Clin. 2020 Dec 18;6(4):2055217320972137. doi: 10.1177/2055217320972137. eCollection 2020 Oct-Dec. Mult Scler J Exp Transl Clin. 2020. PMID: 33414927 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page